Post by BD

First XTRACT™ patient enrolled in Europe On June 1st 2026, the first European patient was enrolled in the XTRACT™ Registry, a prospective, multicentre, single-arm, postmarket registry. This milestone marks an important step in expanding real world performance evidence for the Rotarex™ S Catheter in patients with PAD. "We are proud to have enrolled the first patient in Europe in the XTRACT™ Registry. Expanding the registry into Europe is a critical step to ensure the evidence reflects the diversity of real world clinical practice. Given the variability in treatment pathways, patient profiles, and healthcare systems across the region, it is essential to capture data that is representative of European practice. This will help strengthen clinical understanding of the Rotarex™ S Catheter and support more informed treatment decisions to improve outcomes for patients with PAD.", said Dr. Lichtenberg, European Principal Investigator. Congratulations to Dr. Lichtenberg and his team on leading this important step for evidence based PAD care in Europe. #XTRACTRegistry #RotarexS #PAD #RealWorldEvidence #ClinicalResearch #Europe